EcoDrugPlus

Beta-2 Adrenergic Receptor-Like

Ensembl ID : ENSSTUG00000001260
Gene Symbol: LOC115168228
3 Cross references
189 Possible Orthologues:

Beta-2 Adrenergic Receptor-Like

Ensembl ID : ENSSTUG00000045922
Gene Symbol: LOC115205627
3 Cross references
190 Possible Orthologues:

Beta-2 Adrenergic Receptor-Like

Ensembl ID : ENSSTUG00000004048
Gene Symbol: LOC115153952
3 Cross references
186 Possible Orthologues:

Beta-4c Adrenergic Receptor-Like

Ensembl ID : ENSSTUG00000049969
Gene Symbol: LOC115164526
3 Cross references
190 Possible Orthologues:

Beta-Secretase 1-Like

Ensembl ID : ENSSTUG00000036034
Gene Symbol: LOC115206085
3 Cross references
212 Possible Orthologues:

Beta-Secretase 1-Like

Ensembl ID : ENSSTUG00000021001
Gene Symbol: LOC115163134
3 Cross references
212 Possible Orthologues:

Bifunctional Epoxide Hydrolase 2-Like

Ensembl ID : ENSSTUG00000017252
Gene Symbol: LOC115172954
3 Cross references
197 Possible Orthologues:

Bifunctional Epoxide Hydrolase 2-Like

Ensembl ID : ENSSTUG00000021689
Gene Symbol: LOC115161918
3 Cross references
198 Possible Orthologues:

Bile Acid Receptor-Like

Ensembl ID : ENSSTUG00000007159
Gene Symbol: LOC115197371
3 Cross references
381 Possible Orthologues:

Bile Acid Receptor-Like

Ensembl ID : ENSSTUG00000049815
Gene Symbol: LOC115152176
3 Cross references
381 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSSTUG00000039429
Gene Symbol: BDKRB2
3 Cross references
280 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSSTUG00000016790
Gene Symbol: BDKRB2
3 Cross references
281 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).